ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients
Sign Up to like & getrecommendations! Published in 2018 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-018-4464-y
Abstract: Chemotherapy-induced nausea and vomiting (CINV) is a common toxicity that may impair the quality of life of patients with a variety of early- and end-stage malignancies. In light of recent changes in the optimal management… read more here.
Keywords: esmo; induced nausea; chemotherapy induced; mascc esmo ... See more keywords
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.1
Sign Up to like & getrecommendations! Published in 2021 at "ESMO Open"
DOI: 10.1016/j.esmoop.2021.100198
Abstract: Background Immune checkpoint inhibitors (ICIs) treatment is a breakthrough in managing metastatic solid tumours, but its use is associated with a high financial burden for public health care systems. Validated tools such as the European… read more here.
Keywords: clinical benefit; esmo; cost; metastatic solid ... See more keywords
ESMO Clinical Practice Guidelines: adapting and adopting new approaches for development, implementation and audit
Sign Up to like & getrecommendations! Published in 2022 at "ESMO Open"
DOI: 10.1016/j.esmoop.2021.100344
Abstract: The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines (CPGs), which have been produced since 1999, enable oncologists to embark on evidence-based, state-of-the-art management of their patients. The CPGs are produced by renowned multidisciplinary… read more here.
Keywords: esmo; society medical; esmo clinical; oncology ... See more keywords
11 ESMO 2021 breakthroughs: practicing oncologist’s perceptions on data presentation
Sign Up to like & getrecommendations! Published in 2022 at "ESMO Open"
DOI: 10.1016/j.esmoop.2021.100376
Abstract: Background The European Society for Medical Oncology (ESMO) 2021 conference provided a high number of randomized phase III trial reports, many of which were claimed to be practice changing. Given the short time available for… read more here.
Keywords: esmo; 2021 breakthroughs; clinical benefit; presentation ... See more keywords